うつ病のような動作のモデルとしての強制水泳試験
Summary
This protocol describes the forced swim test, which is used for the study of depressive-like behavior in rodents. This procedure involves placing an animal in a container filled with water that eventually will lead to the exhibition of immobility behavior, which is considered to reflect behavioral despair.
Abstract
The goal of the present protocol is to describe the forced swim test (FST), which is one of the most commonly used assays for the study of depressive-like behavior in rodents. The FST is based on the assumption that when placing an animal in a container filled with water, it will first make efforts to escape but eventually will exhibit immobility that may be considered to reflect a measure of behavioral despair. This test has been extensively used because it involves the exposure of the animals to stress, which was shown to have a role in the tendency for major depression. Additionally, the FST has been shown to share some of the factors that are influenced or altered by depression in humans, including changes in food consumption, sleep abnormalities and drug-withdrawal-induced anhedonia. The main advantages of this procedure are that it is relatively easy to perform and that its results are easily and quickly analyzed. Moreover, its sensitivity to a broad range of antidepressant drugs that makes it a suitable screening test is one of the most important features leading to its high predictive validity. Despite its appeal, this model has a number of disadvantages. First, the issue of chronic augmentation is problematic in this test because in real life patients need to be treated for at least several weeks before they experience any relief from their symptoms. Last, due to the aversiveness of the FST, it is important to take into account possible influences it might have on brain structure/function if brain analyses are to be carried out following this procedure.
Introduction
うつ病は、生命を脅かす精神疾患と5％の発生率15〜20％で生涯有病率を持つ世界的な公衆衛生上の大きな関心事である。また、それは2020年までにうつ病は病気1,2の負担にトップ3の貢献者になると推定されている。うつ病は障害と関連付けられて、健康関連コストの増加、生活の質の低下および3,4- .Currentの薬理学的治療処置は、有効性が限られていると関連付けられている心臓血管、代謝性および神経精神障害を含む多くの疾患のための主要な危険因子と考えられている多くの有害な副作用5,6。そのため、革新的で改善された治療法の開発と並んで、この障害の病態生理のより良い理解は重要なままです。したがって、動物モデルは、この分野の研究を進めるために必須である。
この疾患の研究（のために使用される多くのモデルがあります<EM>例えば、スクロース選好テストも、このモデル7,8の開発者の後ポルソルトの試験として知ら強制水泳試験（FST、と、尾懸垂試験））が最も一般的に使用されるアッセイ7,9-12の一つである。
FST中の動物は、それが逃げることができ、そこから水を満たした容器内に配置される。動物は、最初に脱 出しようとしますが、最終的に（ すなわち水上記の鼻を維持するために必要なものを除き、運動をしない場合とフローティング）不動を示すであろう。 FSTは、多くの理由のための動物研究で非常に人気のモデルです。まず、大うつ病12-14傾向に役割を有することが示された応力に対する動物の曝露を伴う。また、うつ病は、多くの場合、ストレス15-17で処理する能力の欠如と見られている。第二に、試験前に抗うつ薬理学的治療は、<FSTにおいて不動を減少することが示されているSUP> 18-23。したがって、多くの場合、潜在的な抗うつ特性15-17,24を有する新規化合物のスクリーニングアッセイとして使用されている。さらに、FSTは、食物消費の変化、睡眠異常および薬物離脱誘発性無快感症15-17,24、ヒトにおけるうつ病の影響を受ける、または変更される因子のいくつかを共有することが示されている。これはまた、このテストは時々 25,26（「野生型」マウスと比較して）基底不動の増加または減少を、変異マウスにおける抑うつ様行動を評価するために使用される理由である。
Protocol
Representative Results
Discussion
FSTは、うつ病のような行動を監視するために使用され、不動の行動絶望3の測定値を反映するという仮定に基づいている。この手順の主な利点は、比較的簡単な操作と高速な結果にある。また、適切なスクリーニング試験は、その高い予測妥当29に至る最も重要な特徴の1つであるせる抗うつ薬の広い範囲に対する感受性。重要なことに、この試験はまた、抗不安効果3,30を<…
Declarações
The authors have nothing to disclose.
Acknowledgements
This research was supported by the Israel Science Foundation (grant No. 738/11), by the National Institute for Psychobiology in Israel (NIPI-7-2011-12), and by the Open University Foundation
Materials
| Name of Material/ Equipment | Company | Catalog Number | Comments/Description | |
| Computer | Dell | intel(r) core(tm) i3-2120 cpu @ 3.30ghz, 4GB ram | ||
| Camera | VIDO | AU-CB422 | B/W CCD CAMERA http://www.vido-europe.com/products_detail.asp?id=33&pcategory=2 |
|
| Coding software | Biobserve | FST Analysis http://www.biobserve.com/products/fst/index.html |
||
| Heating lamp | Ikea | AA-19025-3 | ESPRESSIVIO 400.504.46 - 20W G4 Bulb http://www.ikea.com/ms/en_US/customer_service/assembly/E/E00050467.pdf |
|
| Heating pillow | Sachs | EF-188B | 38*38cm Heating pillow http://www.sachs.co.il/eng/lego_tree.php?instance_id=21&actions=show&id= 604 |
Referências
- Levinson, D. F. The genetics of depression: a review. Biological psychiatry. 60, 84-92 (2006).
- Murray, C. J., Lopez, A. D. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 349, 1498-1504 (1997).
- Cryan, J. F., Holmes, A. The ascent of mouse: advances in modelling human depression and anxiety. Nature reviews. Drug discovery. 4, 775-790 (2005).
- Thase, M. E. Managing depressive and anxiety disorders with escitalopram. Expert opinion on pharmacotherapy. 7, 429-440 (2006).
- Lam, R. W., Kennedy, S. H. Evidence-based strategies for achieving and sustaining full remission in depression: focus on metaanalyses. Canadian journal of psychiatry. Revue canadienne de psychiatrie. 49, 17S-26S (2004).
- Dording, C. M., et al. The pharmacologic management of SSRI-induced side effects: a survey of psychiatrists. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. 14, 143-147 (2002).
- Porsolt, R. D., Le Pichon, M., Jalfre, M. Depression: a new animal model sensitive to antidepressant treatments. Nature. 266, 730-732 (1977).
- Porsolt, R. D., Bertin, A., Jalfre, M. Behavioral despair in mice: a primary screening test for antidepressants. Archives internationales de pharmacodynamie et de therapie. 229, 327-336 (1977).
- Cryan, J. F., Markou, A., Lucki, I. Assessing antidepressant activity in rodents: Recent developments and future needs. Trends in Pharmacological Sciences. 23, 238-245 (2002).
- Cryan, J. F., et al. Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors. Proceedings of the National Academy of Sciences of the United States of America. 101, 8186-8191 (2004).
- Porsolt, R. D., Anton, G., Blavet, N., Jalfre, M. Behavioural despair in rats: A new model sensitive to antidepressant treatments. European Journal of Pharmacology. 47, 379-391 (1978).
- Doron, R., et al. A novel herbal treatment reduces depressive-like behaviors and increases BDNF levels in the brain of stressed mice. Life sciences. 94, 151-157 (2014).
- Caspi, A., et al. Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science. 301, 386-389 (2003).
- Kaufman, J., et al. Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biological psychiatry. 59, 673-680 (2006).
- Anisman, H., Zacharko, R. M. Multiple neurochemical and behavioral consequences of stressors: Implications for depression. Pharmacology and Therapeutics. 46, 119-136 (1990).
- Kessler, R. C. The effects of stressful life events on depression. Annual Review of Psychology. 48, 191-214 (1997).
- Sullivan, P. F., Neale, M. C., Kendler, K. S. Genetic epidemiology of major depression: Review and meta-analysis. American Journal of Psychiatry. 157, 1552-1562 (2000).
- Cryan, J. F., Valentino, R. J., Lucki, I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neuroscience and biobehavioral reviews. 29, 547-569 (2005).
- Detke, M. J., Lucki, I. Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: The effects of water depth. Behavioural Brain Research. 73, 43-46 (1996).
- Hemby, S. E., et al. Potential antidepressant effects of novel tropane compounds, selective for serotonin or dopamine transporters. Journal of Pharmacology and Experimental Therapeutics. 282, 727-733 (1997).
- Bouvard, M., Stinus, L. In the rat forced swimming test, chronic but not subacute administration of dual 5-HT/NA antidepressant treatments may produce greater effects than selective drugs. Behavioural Brain Research. 136, 521-532 (2002).
- Page, M. E., Detke, M. J., Dalvi, A., Kirby, L. G., Lucki, I. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology. 147, 162-167 (1999).
- Rubalcava, C., Lucki, I. Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test. Neuropsychopharmacology. 22, 191-199 (2000).
- Cryan, J. F., Mombereau, C., Vassout, A. The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice. Neuroscience and biobehavioral reviews. 29, 571-625 (2005).
- Cryan, J. F., Mombereau, C. In search of a depressed mouse: Utility of models for studying depression-related behavior in genetically modified mice. Molecular Psychiatry. 9, 326-357 (2004).
- Sang, K. P., et al. Par-4 links dopamine signaling and depression. Cell. 122, 275-287 (2005).
- Doron, R., et al. Anxiolytic effects of a novel herbal treatment in mice models of anxiety. Life sciences. 90, 995-1000 (2012).
- Doron, R., et al. Escitalopram or novel herbal mixture treatments during or following exposure to stress reduce anxiety-like behavior through corticosterone and BDNF modifications. PloS one. 9, e91455 (2014).
- Borsini, F., Meli, A. Is the forced swimming test a suitable model for revealing antidepressant activity. Psychopharmacology. 94, 147-160 (1988).
- Reinhold, J. A., Mandos, L. A., Rickels, K., Lohoff, F. W. Pharmacological treatment of generalized anxiety disorder. Expert opinion on pharmacotherapy. 12, 2457-2467 (2011).
- Estrada-Camarena, E., Fernandez-Guasti, A., Lopez-Rubalcava, C. Interaction between estrogens and antidepressants in the forced swimming test in rats. Psychopharmacology. 173, 139-145 (2004).
- Weiss, J. M., Kilts, C. D. Animal models of depression and schizophrenia. Textbook of Psychopharmacology. , 89-131 (1998).
- Armario, A., Gavaldà, A., Martí, J. Comparison of the behavioural and endocrine response to forced swimming stress in five inbred strains of rats. Psychoneuroendocrinology. 20, 879-890 (1995).
- Paré, W. P. Open field, learned helplessness, conditioned defensive burying, and forced-swim tests in WKY rats. Physiology and Behavior. 55, 433-439 (1994).
- Overstreet, D. H., Friedman, E., Mathe, A. A., Yadid, G. The Flinders Sensitive Line rat: a selectively bred putative animal model of depression. Neuroscience and biobehavioral reviews. 29, 739-759 (2005).
- Piras, G., Piludu, M. A., Giorgi, O., Corda, M. G. Effects of chronic antidepressant treatments in a putative genetic model of vulnerability (Roman low-avoidance rats) and resistance (Roman high-avoidance rats) to stress-induced depression. Psychopharmacology. 231, 43-53 (2014).
- Bielajew, C., et al. Strain and Gender Specific Effects in the Forced Swim Test. Effects of Previous Stress Exposure. Stress. 6, 269-280 (2003).
- Fujisaki, C., et al. An immnosuppressive drug, cyclosporine-A acts like anti-depressant for rats under unpredictable chronic stress. Journal of Medical and Dental Sciences. 50, 93-100 (2003).
- Gomez, R., Vargas, C. R., Wajner, M., Barros, H. M. T. Lower in vivo brain extracellular GABA concentration in diabetic rats during forced swimming. Brain research. 968, 281-284 (2003).
- Hilakivi-Clarke, L. A., Wozniak, K. M., Durcan, M. J., Linnoila, M. Behavior of streptozotocin-diabetic mice in tests of exploration, locomotion, anxiety, depression and aggression. Physiology and Behavior. 48, 429-433 (1990).
- Cryan, J. F., Hoyer, D., Markou, A. Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents. Biological psychiatry. 54, 49-58 (2003).
- Portella, M. J., et al. Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression. The Journal of clinical psychiatry. 72, 962-969 (2011).
- Machado-Vieira, R., Salvadore, G., Luckenbaugh, D. A., Manji, H. K., Zarate, C. A. Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder. The Journal of clinical psychiatry. 69, 946-958 (2008).
- Bordet, R., Thomas, P., Dupuis, B. Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. Reseau de Recherche et d’Experimentation Psychopharmacologique. The American journal of psychiatry. 155, 1346-1351 (1998).
- Dulawa, S. C., Holick, K. A., Gundersen, B., Hen, R. Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology. 29, 1321-1330 (2004).
- Willner, P. Animal models of depression: An overview. Pharmacology and Therapeutics. 45, 425-455 (1990).
- Jefferys, D., Funder, J. The effect of water temperature on immobility in the forced swimming test in rats. European Journal of Pharmacology. 253, 91-94 (1994).
- West, A. P. Neurobehavioral studies of forced swimming: The role of learning and memory in the forced swim test. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 14, 863-877 (1990).
- De Pablo, J. M., Parra, A., Segovia, S., Guillamon, A. Learned immobility explains the behavior of rats in the forced swimming test. Physiology and Behavior. 46, 229-237 (1989).
- Dal-Zotto, S., Martí, O., Armario, A. Influence of single or repeated experience of rats with forced swimming on behavioural and physiological responses to the stressor. Behavioural Brain Research. 114, 175-181 (2000).
- Rittenhouse, P. A., López-Rubalcava, C., Stanwood, G. D., Lucki, I. Amplified behavioral and endocrine responses to forced swim stress in the Wistar-Kyoto rat. Psychoneuroendocrinology. 27, 303-318 (2002).
- Overstreet, D. H., Keeney, A., Hogg, S. Antidepressant effects of citalopram and CRF receptor antagonist CP-154,526 in a rat model of depression. European Journal of Pharmacology. 492, 195-201 (2004).
- Chaki, S., et al. MGS0039: A potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity. Neuropharmacology. 46, 457-467 (2004).
- Mague, S. D., et al. Antidepressant-like effects of κ-opioid receptor antagonists in the forced swim test in rats. Journal of Pharmacology and Experimental Therapeutics. 305, 323-330 (2003).
- Molina-Hernández, M., Téllez-Alcántara, N. P. Antidepressant-like actions of pregnancy, and progesterone in Wistar rats forced to swim. Psychoneuroendocrinology. 26, 479-491 (2001).
- Estrada-Camarena, E., Fernández-Guasti, A., López-Rubalcava, C. Antidepressant-like effect of different estrogenic compounds in the forced swimming test. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 28, 830-838 (2003).
- Gersner, R., Gordon-Kiwkowitz, M., Zangen, A. Automated behavioral analysis of limbs’ activity in the forced swim test. Journal of neuroscience. 180, 82-86 (2009).
- Einat, H. Partial effects of the protein kinase C inhibitor chelerythrine in a battery of tests for manic-like behavior in black Swiss mice. Pharmacological reports : PR. 66, 722-725 (2014).
